SCHEMBL20404139

SCHEMBL20404139

OC1[C@@H](O)CCC[C@H]1Nc1nc(-c2c[nH]c3ncc(Cl)cc23)ncc1F

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL10304192 1.00 — —
SCHEMBL15723344 1.00 — —
SCHEMBL10304614 1.00 — —
SCHEMBL19988435 1.00 — —
SCHEMBL19988433 1.00 — —
SCHEMBL20404137 1.00 — —
SCHEMBL10304296 1.00 — —
SCHEMBL10007727 1.00 — —
SCHEMBL21014872 1.00 — —
SCHEMBL10008896 1.00 — —

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3427738-B1 INHIBITORS OF INFLUENZA VIRUSES REPLICATION VERTEX PHARMA (US) 2021-12-01 — — EP disclosed
EP-3427738-A1 INHIBITORS OF INFLUENZA VIRUSES REPLICATION Vertex Pharmaceuticals Incorporated (US) 2019-01-16 — — EP disclosed
EP-3141252-B1 INHIBITORS OF INFLUENZA VIRUSES REPLICATION VERTEX PHARMA (US) 2018-07-25 — — EP disclosed
Send feedback